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Abstract
Although there is significant evidence of a cancer epidemic in Africa, there is limited awareness about cancer in
most African countries. By partnering with international organizations and institutions such as the University of
Florida and the Prostate Net, the African Organisation for Research and Training in Cancer (AORTIC) is committed
to improving cancer advocacy in Africa. This paper presents some of the recent efforts on cancer advocacy in
Africa, including the results of a SWOT analysis conducted for the cancer advocacy workshop and the guidelines
developed by cancer advocates on best practices for cancer advocacy in Africa. One of the outcomes of these
efforts is the African Cancer Advocates Consortium (ACAC) founded by cancer advocates in Africa to,
“Make Cancer a Top Priority in Africa”. While we have started the work to strengthen cancer advocacy in Africa,
we still have a long way to go. Our goal of making cancer a priority in Africa can mainly be achieved by: (1)
increasing the manpower for cancer advocacy through education and training; and (2) strengthening the network
of cancer advocates across the continent.
Background
An organization that has been in the forefront of fighting
cancer in Africa is the African Organisation for Research
and Training in Cancer (AORTIC). AORTIC is committed
to improving cancer advocacy in Africa by advancing
effective cancer control policies and program implementa-
tion in the continent. In line with this goal, AORTIC part-
nered with the University of Florida and the Prostate Net
to implement the first biennial International Workshop on
Cancer Advocacy for African Countries (CAAC) on
November 29, 2011 during the AORTIC’s 8th Interna-
tional Cancer Conference in Cairo, Egypt. To better
understand cancer advocacy in Africa, a cancer advocacy
SWOT analysis was conducted prior to the cancer advo-
cacy workshop. A SWOT Analysis is a strategic planning
tool used to evaluate the strengths, weaknesses, opportu-
nities, and threats involved in a project. We conducted a
survey of leading African cancer advocates through online
and electronic mail submissions. A copy of the SWOT
analysis survey instrument is provided in Additional file 1.
The results of the SWOT analysis were used to prepare
for the cancer advocacy workshop.
At the end of the CAAC international workshop, the
African Cancer Advocates Consortium (ACAC) was
founded to “Make Cancer a Top Priority in Africa”.
The ACAC currently comprises 51 members from
diverse countries in Africa and is led by African cancer
advocates. The consortium focuses on six advocacy
areas[1]:
1. Political Advocacy, to lobby in order to impact
public policy at local, state, and federal levels;
2. Education Advocacy to enhance cancer informa-
tion and education;
3. Research Advocacy to foster high quality cancer
research that meets the needs of patients and the
community;
4. Fundraising Advocacy to raise funds to support
cancer research, services, education, and community
outreach;
* Correspondence: fodedina@cop.ufl.edu
1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of
Florida, Gainesville, FL, USA
Full list of author information is available at the end of the article
Odedina et al. Infectious Agents and Cancer 2013, 8(Suppl 1):S8
http://www.infectagentscancer.com/content/8/S1/S8
© 2013 Odedina et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
5. Support Advocacy to support cancer patients,
families, and caregivers; and
6. Community Outreach Advocacy to engage and
reach out to the community to foster cancer control.
A unique initiative that was implemented during the
2011 workshop session was the development of best
practices for cancer advocacy in Africa. The 73 delegates
at the workshop self-selected themselves into six groups
to develop best practices for [1] political advocacy, [2]
support advocacy, [3] fundraising advocacy, [4] commu-
nity outreach advocacy, [5] education advocacy, and [6]
research advocacy. Each group had a facilitator to lead
and moderate the discussions, and a recorder to summar-
ize the discussions. Figures 1 to 4 provides a pictorial
summary of the best practices discussion.
In this paper, we present the results of the SWOT
analysis for the cancer advocacy workshop and the
guidelines developed by 73 cancer advocates on best
practices for cancer advocacy in Africa.
Cancer advocacy in Africa: strengths, weaknesses,
opportunities and threats
An expert panel of five African advocates participated in
the Cancer Advocacy SWOT analyses, identifying the
strengths, weaknesses, opportunities and threats linked to
cancer advocacy in Africa. The key internal conditions
helpful in establishing cancer advocacy in Africa were:
1. Strong women organizations.
2. Strong youth organizations.
3. Widespread use of mobile phone devices and social
media that can be used to share cancer information.
4. Willingness of community to participate in health
promotion.
5. Willingness of faith-based organization to get
involved in cancer advocacy.
6. Willingness of cancer clinicians and scientists to
collaborate with advocates.
7. Committed cancer advocates.
8. Funding from private foundations and pharmaceuti-
cal companies.
9. Empowered patients who become advocates.
On the other hand, the participants identified some
internal conditions harmful to the success of cancer advo-
cacy in Africa. The factors identified by participants were:
1. Competing priorities, such as poverty and illiteracy.
2. Competing public health priorities.
3. Financial barriers.
4. Limited healthcare resources.
5. Lack of awareness and knowledge about cancer
advocacy.
Figure 1 Roundtable discussions by workshop participants to develop best practices for cancer advocacy. The discussions focused on: [1]
Education advocacy; [2] Community Outreach advocacy; [3] Political advocacy; [4] Research advocacy; or [5] Fundraising advocacy.
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Figure 2 Each discussion group had a group facilitator and Note-taker. The note-taking for Cancer Education Advocacy was conducted by Dr. R.
Renee Reams (Florida A&M University, USA).
Figure 3 Mary J Scroggins of In My Sister’s Care and The Pathways Project reporting back on best practices for Research Advocacy.
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6. Lack of knowledge about the disease.
7. Cultural beliefs, including myths and superstitions.
8. Lack of cancer registries to provide accurate and
complete cancer data for advocacy.
9. Absence of National Cancer Plans to guide and
direct cancer control planning.
10. Lack of collaboration among cancer advocates and
non-governmental organizations (NGOs) leading to
fragmentation and duplication of cancer advocacy.
11. Poor health care systems.
12. Limited human resources.
While an understanding of the internal conditions that
affect advocacy is important, it is also imperative to
understand external conditions outside Africa that
impacts advocacy in Africa. The helpful external condi-
tions identified by participants were:
1. Funding support for advocacy.
2. Technical support from international organizations.
3. Training opportunities for cancer advocates.
4. Opportunity to join international advocacy net-
works for support.
5. Collaboration opportunities with clinicians, scien-
tists, and the community.
6. Opportunities to share African realities with advo-
cates from other countries, for example through AOR-
TIC surveys and workshops.
The harmful external conditions identified by partici-
pants include:
1. Unnecessary emphasis on malignancies that are not
of any burden to the health system in Africa.
2. Emphasis on non-Afrocentric ways of doing things.
3. Competing priorities perceived by international
organizations, for example focus on infectious diseases.
4. Lack of funding to support efforts.
5. Misunderstanding of African realities.
Cancer advocacy is still at its infancy in Africa and
faces multiple challenges. The top 10 challenges that
African advocates face include:
1. Lack of funds.
2. Fragmentation or silo approaches in public health-
care policy framing & implementation
3. Lack of interest by the target population due to the
failure of meeting basic needs.
4. Limitations in clinical resources to support advo-
cacy efforts.
5. Competing life/health priorities.
6. Lack of equality in the health care system.
7. Lack of cancer registries.
8. Lack of National Cancer Plans.
9. Lack of political will in dealing with cancer in Africa.
10. Stigmatization of cancer and under-appreciation of
the burden of the disease.
Figure 4 Elected 2011-2013 Leadership Team members for the African Cancer Advocates Consortium (ACAC)
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The key to successful advocacy in Africa depends on
overcoming these challenges. Some of the solutions pro-
posed by participants were:
1. Education and training for advocates, including in
areas of grant writing and networking.
2. Local, state, national, and global collaborations to
share resources.
3. Creating community awareness for bigger acknowl-
edgement of cancer and its treatment and impact.
4. Lobbying for each country to have a cancer registry.
5. Putting pressure on the government to develop a
National Policy and Plan for the prevention and control
of cancer.
6. Development of a funding model that will enhance
collaboration among cancer NGOs rather than competi-
tion for scarce resources.
7. Coordination of cancer funding nationally to elimi-
nate the disparities that exist in different regions, espe-
cially with respect to access to appropriate treatments,
fair distribution of services and more effective service
delivery.
8. Control of the high cost of cancer treatment to
make treatment more available in state and private
sectors.
9. Development of national policies and infrastructure
to manage the burden of cancer in Africa.
10. Development of a platform for addressing cancer
advocacy in Africa, led by experienced and committed
African cancer advocates.
Best practices for cancer advocacy in Africa
The first biennial AORTIC Cancer Advocacy workshop
fostered the development of best practices for cancer
advocacy in Africa. The best practices developed for
each type of advocacy is described below.
Cancer education advocacy
Education advocacy focuses on educating and increasing
cancer awareness of patients, family, and lay public using
diverse media. The best practices suggested for Education
Advocacy were based on the identification of: (i) What
works in Africa; (ii) What has not worked in Africa; and
(iii) What to avoid. Creativity and innovation are impor-
tant for effective cancer education. The Education Advo-
cacy working group identified educational channels,
sources, sites, and strategies that work in Africa. These
include: use of drama to educate the public; providing
education during sports events, such as soccer, which is
popular in Africa; providing education at places of wor-
ship; use of social gatherings such as weddings and fun-
erals; and taking advantages of pre-arranged meetings
such as town hall meetings. The group also emphasized
the importance of media, such as radio and TV, as well
as the new age social media of Face book and Twitter.
On the other hand, the use of traditional channels such
as fliers and community message boards are also impor-
tant, especially in rural communities. When it comes to
the source of the information, cancer survivors, chiefs,
religious leaders and women’s groups were identified as
important sources. What has not worked very well in
Africa is securing the support of politicians, which makes
Political Advocacy very important in Africa. Finally, the
group noted that cancer screening must be avoided if
there is no funding to support patient treatment and fol-
low-up care if diagnosed with cancer. Screening without
a plan for medical care is a big problem and adds to the
stigma of cancer in Africa. This is because when patients
are diagnosed with cancer and do not have funding to
support appropriate care, they are more likely to die.
This continues to confirm the fear of most people that
cancer automatically means dying. It is thus important to
have an effective fundraising effort to support the treat-
ment of those diagnosed with cancer.
Support advocacy
One of the most important aspects of advocacy is provid-
ing support for newly diagnosed cancer patients, survivors,
families, friends and caregivers. The AORTIC Support
Advocacy working group defined cancer support as con-
necting patients, families, and caregivers for help, hope,
and inspiration throughout cancer management and
needs. The best practice identified by the group is that the
patient’s voice in expressing his or her needs is essential
for Support Advocacy. The support could be in terms of
physical, emotional, family, services, information, healthy
lifestyle and financial support. Additional best practices
are to (i) avoid marginalization of the care of patients; (ii)
eliminate disparity of services for underserved patients;
(iii) make deliberate multi-sectoral action plans to foster
cancer care support in Africa; and (iv) facilitate local and
global collaborations for successful Support Advocacy.
Fundraising advocacy
Advocacy requires significant effort and money. Thus,
Fundraising Advocacy is important in order to support
all the other types of advocacy. The best practices iden-
tified by the Fundraising Advocacy working group was
based on what has worked in Africa and included: (i)
Fundraising efforts tailored and targeted to those who
have been affected by cancers (such as families of survi-
vors) and those who benefit financially indirectly or
directly from cancer (such as pharmaceutical companies
and hospitals); (ii) Joint fundraising efforts by multiple
partners to make a larger impact; (iii) Partnering with
local companies or organizations who benefit from the
targeted community, such as super market stores; (iv)
Submitting special requests to the Minister of Health to
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support cancer initiatives; and (v) Making public records
of successes and name of sponsors.
Research advocacy
The fight against cancer can only be won when scientific
research is tailored to the priorities of cancer patients.
Research Advocacy ensures that the voices of cancer
patients and survivors are heard by researchers. The best
practices established by the Research Advocacy working
group are: (i) Training and mentorship for African advo-
cates in the area of Research Advocacy; (ii) Continuous
assessment of priorities of cancer patients; (iii) Partnership
with scientists for active involvement in grant proposals
and research; (iv) Fostering representation of diverse can-
cer patients in biomedical research through active partici-
pants’ recruitment and retention; (v) Encouraging
multidisciplinary team-based, innovative research; and (vi)
Active involvement in human subjects protection by ser-
ving on grant review panels and Institutional Review
Boards (IRBs). Furthermore, the group identified the fol-
lowing priority areas to advocate for research: free access
to scientific literature, effective and efficient IRBs, increase
in innovative research and avoidance of duplicative
research, and community-based research that incorporates
the needs of patients.
Community outreach advocacy
Community Outreach Advocacy is defined by the work-
ing group as an initiative that goes to the grassroots
level. It involves a bi-directional dialogue with the tar-
geted community. Two best practices were identified by
the Community Outreach Advocacy working group: (i)
Conduct needs assessment to appropriately meet the
needs of the community; and (ii) Disseminate informa-
tion back to the community in a timely manner. To
function effectively in a community, advocates should
not work alone but develop partnership with key stake-
holders in the community. Advocates should also avoid
imposing their ideas on the community.
Political advocacy
Political Advocacy is central to making significant
impact on the population as it involves lobbying to
impact public policy at local, state, national and global
level. The best practices identified by the Political Advo-
cacy working group are: (i) Clearly identifying the out-
come desired, for example passing a bill to change
public health policy; (ii) Promoting a multi-disciplinary
advocacy movement; (iii) Lobbing multiple stakeholders;
and (iv) Employing an effective spokesperson for politi-
cal advocacy. For effective lobbying, the targeted person
is very important and has to be an influential person
who can shape public policy, such as political leaders,
spouses of political leaders, religious leaders, and
royalties (kings, chiefs). It is also important to be strate-
gic in getting the attention of public policy change
agents. Examples of what has worked in Africa are con-
sistent contact with political officials through personal
visits, letters, phone calls, and petitions; use of data and
information unique to the constituency of the targeted
person; personal stories of a patient from the constitu-
ency of the targeted person; and providing opportunity
for positive public relations.
Conclusion
While we have started the work to strengthen cancer
advocacy in Africa, we still have a long way to go. Our
objective can mainly be achieved by: (1) increasing the
manpower for cancer advocacy through education and
training; and (2) strengthening the network of cancer
advocates across the continent. Thus, the primary goal of
the biennial CAAC international conference is to train
cancer advocates who will be empowered to engage their
communities, develop, and implement cancer health and
survivorship programs. Utilizing an innovative framework
for its training activities, the biennial workshops will pro-
vide the skills to: (1) mobilize the resources within African
countries for health promotion, prevention, and survivor-
ship strategies; (2) partner with key stakeholders to accom-
plish targeted objectives; (3) raise funds to support
advocacy activities; and (4) develop and successfully orga-
nize community-centered programs.
The theme for the 2nd biennial CAAC workshop,
which will take place in South Africa in 2013 is: “Cancer
Advocacy: Tools for Political, Education, Research, Fun-
draising, Support and Community Outreach Advocacies”.
Based on the feedback from African cancer advocates,
there will be a two-day workshop series: (i) a Master
Trainer workshop proposed to train 25 master trainers
to conduct country- and regional-based advocacy pro-
grams in Africa; and (ii) a general workshop conducted
by the 25 master trainers as part of their experiential
training. Advocates will have the opportunity to share
their advocacy programs through an Advocacy Expo and
Posters session. In addition, within-continent collabora-
tions of advocacy programs will be fostered through the
networking and the ACAC meeting.
The planned 2013 ACAC workshop, which will be held
in conjunction with AORTIC 2013 meeting (http://www.
aortic-africa.org/index.php/conferences/), will significantly
impact cancer advocacy in Africa by providing a forum for
advocates, cancer survivors and community leaders inter-
ested in finding solutions to the cancer epidemic in Africa
to learn, network and initiate collaborative advocacy pro-
jects. This workshop is highly innovative because: (i) It
will develop a critical mass of Master Trainers in Africa;
(ii) It will bring together diverse participants who will
learn from the conference and each other, and who in
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turn will lead the fight against cancer in Africa; and
(iii) There is a significant number of partnering African
institutions and organizations. AORTIC is dedicated to
developing cancer advocacy capability to eliminate cancer
burden in Africa through the workshops and the ACAC.
The biennial workshops offer unique benefits that cannot
be achieved individually.
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